What’s in a Name? PCOS Renamed PMOS —It Was Never Just the Ovaries

Imagine being told for years that you “just have cysts on your ovaries.” You are handed a prescription for birth control pills and sent home. But struggling with periods is not the only issue. Exhaustion, weight gain, skin breaking out, hair thinning, and mood shifts without warning are also issues of concern. For years, your condition had a name, but it was not the right one.

On May 12, 2026, the global medical community finally acknowledged what millions of women have lived with for decades.

PMOS 2026: PCOS renamed PMOS

Polycystic Ovary Syndrome (PCOS) has officially been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS). The paper, published in The Lancet, is the result of a global effort running for more than 14 years, involving 56 leading academic, clinical, and patient organisations, and responses from more than 14,000 respondents worldwide.^1,2 The condition affects more than 170 million women worldwide, which is one in every eight women of reproductive age._¹

So why did the name need to change?

The old term, PCOS, was built around the visible finding of polycystic ovaries, the presence of multiple follicles on ultrasound. But as researchers and patients alike pointed out, not all women with the condition have cysts, and not all women with cysts have the condition. This is a multisystem endocrine and metabolic disorder that affects the heart, the liver, the skin, the brain, and mental health, far beyond the ovaries.

As the authors of The Lancet consensus put it, the term PCOS was

inaccurate, implying pathological ovarian cysts, obscuring diverse endocrine and metabolic features, and contributing to delayed diagnosis, fragmented care, and stigma, while curtailing research and policy framing.¹

The new name,PMOS, breaks down as follows:

• Polyendocrine: the condition involves disruption across multiple hormonal axes, not just reproductive hormones
• Metabolic: insulin resistance, blood sugar dysregulation, dyslipidemia, and cardiovascular risk are central features
• Ovarian: ovarian involvement (anovulation, androgen excess) remains part of the picture, but is no longer the defining lens

Implementation of the PMOS terminology is planned over three years, with the updated international guideline across 195 countries, expected to formally adopt the new terminology by 2028.³

Why the Old Name Was Causing Real Harm

PCOS was framed as a reproductive and gynecological condition, and many women spent years receiving fragmented care. Their cardiovascular risk went unscreened, insulin resistance went unaddressed, and mental health went unacknowledged.

Research has shown that women with PCOS face significantly elevated risks of type 2 diabetes, gestational diabetes, dyslipidemia, hypertension, and cardiovascular disease.^3,4 The ovary-centric framing of the old name meant these risks were often treated as secondary concerns, if they were considered at all.

In global surveys leading up to the name change, 86% of patients and 71% of clinicians supported renaming the condition, citing stigma, confusion, and fragmented care as their primary reasons.³

The name change is, in the words of one patient advocate involved in the process, “more than semantics. It is about finally recognising the full reality of what patients experience.” ⁵

PCOS Ayurveda: Artava Kshaya

आर्तवक्षये यथोचितकालादर्शनम् अल्पता वा योनिवेदनाऽ च
Ārtava-kṣaye yathocita-kālādarśanam alpatā vā yoni-vedanā ca

Meaning:
In diminution of Artava (menstrual flow/reproductive tissue), menstruation may not appear at the proper time, or may be scanty, and there may be pain in the yoni (pelvic/vaginal region).

While modern medicine took more than a decade of global consultation to formally redefine the condition, Ayurvedic texts had long described systemic reproductive and metabolic disturbances that parallel several features now associated with PMOS.

In Ayurveda, what we now call PMOS is most closely correlated with Artava Kshaya, a condition described as a deficiency or loss of artava (the female reproductive tissue and its functional essence), associated with Vata and Kapha dosha predominance. ⁶

The classical lakshanas (features) of Artava Kshaya as described in Ayurvedic texts include:

• Yathochitakala Artava Adarshana — menstrual irregularity
• Alpata — scanty menstruation
• Yoni Vedna — pelvic pain
• Features associated with impaired fertility

These show clinical resemblance to the reproductive features of PMOS.⁶ But the Ayurvedic understanding does not stop at the reproductive system.

The Dosha Framework — A Multisystem View

According to published Ayurvedic research, PCOS/PMOS can be understood through the lens of all three doshas, each producing a distinct clinical picture: ⁷

Kapha predominance manifests as: weight gain, insulin resistance, subfertility, hirsutism, cold intolerance, and diabetic tendencies, which are similar to the metabolic features now central to the PMOS definition. Pitta predominance manifests as: hair loss, acne, painful and clot-heavy menstruation, and cardiovascular tendencies. Vata predominance manifests as scanty or absent menstruation, severe menstrual irregularity, and painful periods.

In other words, Ayurvedic frameworks approached menstrual and reproductive disorders as systemic conditions involving multiple bodily processes. The dosha-based interpretation extended beyond the reproductive system and included metabolic, dermatological, and broader constitutional patterns very much similar to what is now reflected in PMOS.

The Role of Ama and Agni

According to Ayurveda, Artava Kshaya is closely linked to the accumulation of Ama (undigested metabolic waste) and impaired Agni (digestive and metabolic fire).

“रोगाः सर्वेऽपि मन्देऽग्नौ
Rogāḥ sarve’pi mande’gnau — Charaka Samhita

Meaning:

All diseases arise when the digestive fire (Agni) becomes weak.

Ayurvedic texts describe how a sedentary lifestyle, poor dietary habits, stress, and nutritional deficiencies impair Agni, leading to the accumulation of Ama. This Ama creates srotasam lepa, obstruction in the body’s channels, including the Artavavaha Srotas (channels governing reproductive tissue). ⁸

Now, what modern science tells us about PMOS: insulin resistance, the result of impaired metabolic processing, is one of its most central features, present even in non-obese phenotypes.³

Ayurvedic Management: A Whole-Body Approach

Ayurveda approaches this as a systemic disorder involving metabolism, reproduction, and doshic imbalance.

A published clinical study on Ayurvedic management of subfertility with PCOS, conducted over six months with 40 patients, used a three-stage protocol based on Shodhana (purification), Shamana (pacification), and Tarpana (nourishment). Key herbs used included:⁹

• Shatavari (Asparagus racemosus): for correcting hormonal imbalance and supporting follicular maturity
• Shatapushpa (Peucedanum graveolens): for supporting ovulation and relieving menstrual irregularity
• Guduchi (Tinospora cordifolia): for improving immunity and overall vitality

A PMC-published review of Ayurvedic approaches to PCOS management highlights the role of formulations with Agni Deepana (metabolic-stimulating), Lekhana (fat-scraping), and Artavajanana (ovulation-inducing) properties. Trikatu, the combination of ginger, black pepper, and long pepper, is noted for its role in improving metabolism and reducing obesity through increasing digestive enzyme activity. Kanchanara (Bauhinia variegata), a key ingredient in classical formulations, has demonstrated anti-inflammatory and anti-diabetic properties that help address insulin resistance.⁷

Ashwagandha (Withania somnifera), one of Ayurveda’s most well-researched adaptogens, has shown potential in stress modulation and metabolic support, with emerging research exploring its role in women with PCOS.

Lifestyle as Medicine

Both Ayurveda and modern evidence agree that lifestyle is not an adjunct to treatment in PMOS, but it is treatment.

Ayurvedic Dinacharya (daily regimen) principles, regular sleep and wake cycles, seasonal eating, oil massage, stress regulation through yoga and pranayama, directly address the neuroendocrine and metabolic roots of the condition.

From a modern evidence view, the 2023 International Evidence-Based Guideline for PCOS similarly emphasises lifestyle intervention, dietary modification, exercise, and stress reduction, as first-line management, particularly for metabolic features.¹⁰

Conclusion

What makes the renaming of PCOS to PMOS significant is not just the letters. It is the shift it represents. The shift from a condition defined by what could be seen on an ultrasound, to one defined by what is happening across the entire body, the endocrine system, the metabolic system, the reproductive system, the skin, and the mind.

Ayurveda traditionally interpreted such disorders through a whole-body framework rather than an isolated ovarian cause.

The Artava Kshaya, rooted in dosha imbalance, impaired Agni, and Ama accumulation, was always a whole-body understanding of a whole-body condition. It never reduced a woman’s suffering to a finding on an imaging report.

As the global medical community now works to implement this new name across guidelines, medical curricula, and patient resources in 195 countries, it is worth realising what traditional medicine has long understood: that the body is not a collection of isolated organs, and that conditions affecting women deserve to be taken as seriously, and understood as completely, as the complex, multisystem phenomena they are.

For the 170 million women living with this condition, that recognition is long overdue.

---

References

1. Teede HJ, Bahri Khomami M, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet. Published online May 12, 2026. doi:10.1016/S0140-6736(26)00717-8
2. STAT News. PCOS is now called PMOS. The renaming process lasted a decade. May 12, 2026. https://www.statnews.com/2026/05/12/pcos-now-called-pmos-polyendocrine-metabolic-ovarian-syndrome/
3. AJMC. PCOS Renamed PMOS in Landmark Shift Reflecting Metabolic and Endocrine Features. May 2026. https://www.ajmc.com/view/pcos-renamed-pmos-in-landmark-shift-reflecting-metabolic-and-endocrine-features
4. Tay CT, Mousa A, Vyas A, Pattuwage L, Tehrani FR, Teede H. 2023 international evidence-based polycystic ovary syndrome guideline update: insights from a systematic review and meta-analysis on elevated clinical cardiovascular disease in polycystic ovary syndrome. J Am Heart Assoc. 2024;13:e033572. doi:10.1161/JAHA.123.033572
5. Endocrine Society. Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide. May 2026. https://www.endocrine.org/news-and-advocacy/news-room/2026/pcos-name-change
6. Sharma T, Tripathi A. A literary review of Artava Kshaya in Ayurveda W.S.R. to Polycystic Ovarian Syndrome. Int J Innovative Res Technol. 2024;11(6). https://ijirt.org/publishedpaper/IJIRT168979_PAPER.pdf
7. PMC. Ayurvedic Approaches to Holistic Management of Polycystic Ovary Syndrome (PCOS). PMC11805180. https://pmc.ncbi.nlm.nih.gov/articles/PMC11805180/
8. Jain CR, Ganu R. A Comprehensive Ayurvedic Perspective of Polycystic Ovary Syndrome (PCOS). IJIRT. November 2024. https://ijirt.org/publishedpaper/IJIRT168979_PAPER.pdf
9. Siriwardene SA, et al. Clinical efficacy of Ayurveda treatment regimen on subfertility with Poly Cystic Ovarian Syndrome (PCOS). Ayu. 2010;31(1). PMC3215317. doi:10.4103/0974-8520.68203
10. Teede HJ, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol. 2023;189:G43–G64.

---

AI Disclosure

HealthOdysseyHub maintains full transparency in content creation. Some articles may include limited assistance from Artificial Intelligence (AI) tools for grammar, phrasing, or structure under strict human editorial supervision. All scientific and medical information is reviewed and approved by qualified professionals before publication, in alignment with ethical guidelines.

Disclaimer

The information on HealthOdysseyHub is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. We strive to keep our content accurate and up-to-date, but healthcare knowledge changes quickly. Always consult a qualified healthcare professional before making decisions based on our content. Some topics may cover alternative or complementary medicine. These may not align with conventional practices. Approach such information with caution and seek multiple opinions before any medical intervention.